AngioLab Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Public

  • Employees
  • 16

Employees

  • Stock Symbol
  • 251280

Stock Symbol

  • Share Price
  • $1.64
  • (As of Thursday Closing)

AngioLab General Information

Description

AngioLab Inc is a biotechnology company. It is developing pharmaceuticals and health functional foods based on the inhibition of angiogenesis. The group is developing natural products and antibody-based pharmaceuticals.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 65, Techno 3-ro
  • Number 159, Gwanpyeong-dong, Hanshin S&M
  • Daejeon, Yuseong 305-509
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
KRX
Vertical(s)
Corporate Office
  • 65, Techno 3-ro
  • Number 159, Gwanpyeong-dong, Hanshin S&M
  • Daejeon, Yuseong 305-509
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AngioLab Stock Performance

As of 19-Nov-2026, AngioLab’s stock price is $1.64. Its current market cap is $5.12M.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.64 $1.57 $1.01 - $2.86 $5.12M 1.45K -$0.14

AngioLab Financials Summary

As of 31-Dec-2025, AngioLab has a trailing 12-month revenue of $1.59M.

In Thousands,
USD
TTM 31-Dec-2025 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 4,851 4,851 13,691 13,843
Revenue 1,591 1,591 1,498 380
EBITDA (352) (352) (553) (1,765)
Net Income (390) (390) (582) (1,775)
Total Assets 1,874 1,874 1,548 3,041
Total Debt 15 15 57 81
Public Fundamental Data provided by Morningstar, Inc. disclaimer

AngioLab Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore AngioLab‘s full profile, request access.

Request a free trial

AngioLab Patents

AngioLab Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022340371-A1 Composition comprising horse chestnut extract Pending 01-Sep-2021
CA-3226434-A1 Composition comprising horse chestnut extract Pending 01-Sep-2021
EP-4395802-A1 Composition comprising horse chestnut extract Pending 01-Sep-2021
EP-4395802-A4 Composition comprising horse chestnut extract Pending 01-Sep-2021
US-20240325484-A1 Composition comprising horse chestnut extract Pending 01-Sep-2021 A61K36/77
To view AngioLab’s complete patent history, request access »

AngioLab Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AngioLab Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore AngioLab‘s full profile, request access.

Request a free trial

AngioLab ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view AngioLab’s complete esg history, request access »

AngioLab FAQs

  • When was AngioLab founded?

    AngioLab was founded in 1999.

  • Where is AngioLab headquartered?

    AngioLab is headquartered in Daejeon, South Korea.

  • What is the size of AngioLab?

    AngioLab has 16 total employees.

  • What industry is AngioLab in?

    AngioLab’s primary industry is Drug Discovery.

  • Is AngioLab a private or public company?

    AngioLab is a Public company.

  • What is AngioLab’s stock symbol?

    The ticker symbol for AngioLab is 251280.

  • What is the current stock price of AngioLab?

    As of 19-Nov-2026 the stock price of AngioLab is $1.64.

  • What is the current market cap of AngioLab?

    The current market capitalization of AngioLab is $5.12M.

  • What is AngioLab’s current revenue?

    The trailing twelve month revenue for AngioLab is $1.59M.

  • What is AngioLab’s annual earnings per share (EPS)?

    AngioLab’s EPS for 12 months was -$0.14.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process